Medicare drug price rule may target under-the-skin cancer immunotherapies
For 2029, a federal rule proposes closing a “loophole” that protects medicines transitioning from intravenous administration from price protection.
Medicare drug price rule may target under-the-skin cancer immunotherapies Read More »
